期刊
PROSTAGLANDINS & OTHER LIPID MEDIATORS
卷 100, 期 -, 页码 1-14出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.prostaglandins.2012.11.003
关键词
Cannabinoid; Cytosolic phospholipase A(2); ERK1/2; NF-kappa B; Inducible nitric oxide synthase; Reactive oxygen species
资金
- National Multiple Sclerosis Society [RG3741]
- Defense Medical Research and Development Program [0130-10-00003-00002]
- Uniformed Services University [R0701Z, R070UX]
Cannabinoids have been consistently shown to suppress microglia activation and the release of cytotoxic factors including nitric oxide, superoxide and proinflammatory cytokines. However, the underlying molecular mechanisms and whether the action of cannabinoids is coupled to the activation of cannabinoid type 1 (CB1) and type 2 (CB2) receptors are still poorly defined. In this study we observed that the CB1 and CB2 receptor non-selective or selective agonists dramatically attenuate iNOS induction and ROS generation in LPS-activated microglia. These effects are due to their reduction of phosphorylation of extracellular signal regulated kinase 1/2 (ERK1/2), cytosolic phospholipase A(2) (cPLA(2)) and activation of NF-kappa B. Surprisingly, instead of reversing the effect of the respective CB1 and CB2 receptor agonists, the antagonists also suppress iNOS induction and ROS generation in activated microglia by similar mechanisms. Taken together, these results indicate that both cannabinoid receptor agonists and antagonists might suppress microglia activation by CB1 and CB2 receptor independent mechanisms, and provide a new insight into the mechanisms of microglia inhibition by cannabinoids. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据